Skip to content
NBDC Human Database

No datasets in the cart.

Go to the cart

Due to system maintenance, the application system, application review by the Data Access Committee will be unavailable during the following period.
Schedule: October 5th (Mon), 2026, 9:00 - October 7th (Wed), 2026, 15:00 (JST)
We apologize for any inconvenience this may cause and appreciate your understanding.

We are currently receiving a large number of applications for data submission, and the review process is taking longer than usual.We sincerely apologize for the delay and kindly ask for your understanding. When submitting an application, we would greatly appreciate it if you could allow sufficient time for the processing.

Following a change to our organizational structure effective April 1, 2026, this division has been renamed from the "Database Center for Life Science, Joint Support-Center for Data Science Research" to the "Database Division for Life Science (DBCLS), BioData Science Initiative (BSI), National Institute of Genetics (NIG)". Where the former name still appears in the guidelines, please read it as the new name.

Dataset ID

JGAD000089

Type of data
NGS (Exome)
Access criteria
Controlled-access (Type I)
Total data volume
1.2 TB
File formats
  • FASTQ
Research
hum0065
Date published
2020-09-28
Date modified
2020-11-18
DDBJ Search
JGAD000089 (opens in a new tab)
JGA Study
JGAS000089 (opens in a new tab)

Analysis method

WES

Materials and participants
colorectal cancer: 8 cases, lung cancer: 2 cases, small cell carcinoma of uterine cervix: 2case
1. blood cells: 12 samples
(colorectal cancer: 8 samples, lung cancer: 2 samples, small cell carcinoma of uterine cervix: 2samples)
2. CTOS (primary culture): CTOS derived from patient tumors: 5 samples
(colorectal cancer: 2 samples, lung cancer: 2 samples, small cell carcinoma of uterine cervix: 1 sample)
3. CTOS (subculture):
a. CTOS prepared from a CTOS (the same as 2)-derived mouse xenograft: 14 samples
1st subculture: 1 sample (colorectal cancer: 1 sample)
2nd subculture: 4 samples (small cell carcinoma of uterine cervix: 1 sample, colorectal cancer: 3 samples)
3rd subculture: 5 samples (colorectal cancer: 3 samples, lung cancer: 2 samples)
5th subculture: 4 samples (colorectal cancer: 2 samples, lung cancer: 2 samples)
b. CTOS (the same as 2) cultured in vitro: 3 samples (lung cancer: 2 samples, colorectal cancer: 1 sample)
2nd subculture: 1 sample (lung cancer: 1 sample)
5th subculture: 2 samples (lung cancer: 1 sample, colorectal cancer: 1 sample)
  • Health status
    Affected
  • Subject count
    12 (Individual)
Sample description
DNAs extracted from blood cells and CTOSs
  • Tissue
    CTOS, Peripheral blood
  • Tumor / normal
    Mixed
Sample provider
N/A
Experimental method
WES
Target
N/A
Reagent kit
SureSelect Human All Exon V5 + lincRNA
Fragmentation
Ultrasonic fragmentation (Covaris, E220)
Platform
Illumina HiSeq 2000
Read type
Paired-end
Read length
100 bp
Phenotype data
Included
Data use policy
NBDC data sharing policy (JGAP000001)